Blood Glucose Monitoring Device Market Size, Share, Trends, Industry Analysis Report: By Product, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa)

Description

List of Tables

The blood glucose monitoring devices market size is expected to reach USD 31.31 billion by 2034, according to a new study by Polaris Market Research. The report "Blood Glucose Monitoring Devices Market Size, Share, Trends, Industry Analysis Report: By Product, End-Use, and Region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa) - Market Forecast, 2025-2034." gives a detailed insight into current market dynamics and provides analysis on future market growth.

The blood glucose monitoring devices market encompasses technologies designed to measure and manage blood glucose levels, which are crucial for diabetic patients. The rising global prevalence of diabetes, driven by unhealthy lifestyles, aging populations, and genetic factors, has significantly increased the demand for effective glucose management solutions. As awareness of the importance of monitoring blood glucose levels continues to grow, both patients and healthcare providers are advancing these technologies to enhance diabetes care.

Technological advancements are playing a crucial role in the growth of the blood glucose monitoring devices market. Innovations such as non-invasive glucose monitoring, improved sensor accuracy, and enhanced connectivity features in modern devices are making blood glucose monitoring more efficient and user-friendly. These advancements contribute to better disease management and improved patient outcomes, driving increased demand.

For instance, in July 2023, Dexcom, Inc. launched the next-generation Dexcom G7 Continuous Glucose Monitoring System, certified by Health Canada. This system is designed for individuals with diabetes aged two years and older.

The increasing adoption of wearable devices and smart glucose monitors is driving growth in real-time tracking and seamless data integration. The shift toward home-based testing, coupled with rising healthcare spending in emerging markets, further supports this trend. Companies that prioritize user-friendly, accurate, and affordable solutions, along with strategic partnerships and global market expansion, are well-positioned to capitalize on this growing trend.

Blood Glucose Monitoring Devices Market Report Highlights

By product outlook, the self-monitoring devices segment dominated the market in 2024, mainly due to increasing consumer awareness, the convenience of home testing, and the rising prevalence of diabetes.

The hospitals & clinics segment is expected to register the fastest CAGR due to the growing number of diabetic patients, increasing hospital admissions, advancements in technology, and a rising emphasis on continuous glucose monitoring for better patient management.

North America dominated the market in 2024 due to factors such as the high prevalence of diabetes and advanced healthcare infrastructure in countries like the United States and Canada.

Asia Pacific is expected to register the fastest CAGR, owing to the rising prevalence of diabetes in countries such as China and India, where increasing urbanization and lifestyle changes contribute to higher diabetes rates.

The key market players include Abbott Laboratories; Acon Laboratories Inc.; ARKRAY Inc.; Bayer AG; Becton, Dexcom, Inc.; F. Hoffmann-La Roche Ltd.; Medtronic Plc; Johnson & Johnson; Novo Nordisk A/S; Sanofi; Terumo Corporation; Ypsomed.

Polaris Market Research has segmented the blood glucose monitoring devices market report based on product, end-use, and region:

By Product Outlook (Revenue - USD Billion, 2020-2034)

Self-monitoring Devices
Blood Glucose Meter
Testing Strips
Lancets
Continuous Blood Glucose Monitoring Devices
Sensors
Transmitter & Receiver
Insulin Pumps

By End-Use Outlook (Revenue-USD Billion, 2020-2034)

Hospitals & Clinics
Diagnostic Centers
Home Care Settings

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of the Middle East & Africa

Product Code: PM1564

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Blood Glucose Monitoring Device Market Insights

4.1. Blood Glucose Monitoring Device Market - Market Snapshot
4.2. Blood Glucose Monitoring Device Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rise in Advanced Blood Glucose Monitoring Devices
  - 4.2.1.2. Increasing Aging Population
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Availability of substitutes and high cost
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Blood Glucose Monitoring Device Market Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Blood Glucose Monitoring Device Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
5.3. Self-Monitoring Devices
- 5.3.1. Global Blood Glucose Monitoring Device Market, by Self-Monitoring Devices, by Region, 2020-2034 (USD Billion)
- 5.3.2. Blood Glucose Meter
  - 5.3.2.1. Global Blood Glucose Monitoring Device Market, by Blood Glucose Meter, by Region, 2020-2034 (USD Billion)
- 5.3.3. Testing Strips
  - 5.3.3.1. Global Blood Glucose Monitoring Device Market, by Testing Strips, by Region, 2020-2034 (USD Billion)
- 5.3.4. Lancets
- 5.3.5. Global Blood Glucose Monitoring Device Market, by Lancets, by Region, 2020-2034 (USD Billion)
5.4. Continuous Blood Glucose Monitoring Devices
- 5.4.1. Global Blood Glucose Monitoring Device Market, by Continuous Blood Glucose Monitoring Devices, by Region, 2020-2034 (USD Billion)
- 5.4.2. Sensors
- 5.4.3. Global Blood Glucose Monitoring Device Market, by Sensors, by Region, 2020-2034 (USD Billion)
- 5.4.4. Transmitter & Receiver
- 5.4.5. Global Blood Glucose Monitoring Device Market, by Transmitter & Receiver, by Region, 2020-2034 (USD Billion)
- 5.4.6. Insulin Pumps
- 5.4.7. Global Blood Glucose Monitoring Device Market, by Insulin Pumps, by Region, 2020-2034 (USD Billion)

6. Global Blood Glucose Monitoring Device Market, by End Use

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
6.3. Hospitals & Clinics
- 6.3.1. Global Blood Glucose Monitoring Device Market, by Hospitals & Clinics, by Region, 2020-2034 (USD Billion)
6.4. Diagnostic Centers
- 6.4.1. Global Blood Glucose Monitoring Device Market, by Diagnostic Centers, by Region, 2020-2034 (USD Billion)
6.5. Home Care Settings
- 6.5.1. Global Blood Glucose Monitoring Device Market, by Home Care Settings, by Region, 2020-2034 (USD Billion)

7. Global Blood Glucose Monitoring Device Market, by Geography

7.1. Key Findings
7.2. Introduction
- 7.2.1. Blood Glucose Monitoring Device Market Assessment, By Geography, 2020-2034 (USD Billion)
7.3. Blood Glucose Monitoring Device Market - North America
- 7.3.1. North America: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.3.2. North America: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.3.3. Blood Glucose Monitoring Device Market - U.S.
  - 7.3.3.1. U.S.: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.3.3.2. U.S.: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.3.4. Blood Glucose Monitoring Device Market - Canada
  - 7.3.4.1. Canada: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.3.4.2. Canada: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
7.4. Blood Glucose Monitoring Device Market - Europe
- 7.4.1. Europe: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.4.2. Europe: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.3. Blood Glucose Monitoring Device Market - UK
  - 7.4.3.1. UK: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.4.3.2. UK: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.4. Blood Glucose Monitoring Device Market - France
  - 7.4.4.1. France: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.4.4.2. France: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.5. Blood Glucose Monitoring Device Market - Germany
  - 7.4.5.1. Germany: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.4.5.2. Germany: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.6. Blood Glucose Monitoring Device Market - Italy
  - 7.4.6.1. Italy: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.4.6.2. Italy: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.7. Blood Glucose Monitoring Device Market - Spain
  - 7.4.7.1. Spain: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.4.7.2. Spain: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.8. Blood Glucose Monitoring Device Market - Netherlands
  - 7.4.8.1. Netherlands: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.4.8.2. Netherlands: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.9. Blood Glucose Monitoring Device Market - Russia
  - 7.4.9.1. Russia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.4.9.2. Russia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.4.10. Blood Glucose Monitoring Device Market - Rest of Europe
  - 7.4.10.1. Rest of Europe: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.4.10.2. Rest of Europe: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
7.5. Blood Glucose Monitoring Device Market - Asia Pacific
- 7.5.1. Asia Pacific: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.5.2. Asia Pacific: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.3. Blood Glucose Monitoring Device Market - China
  - 7.5.3.1. China: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.5.3.2. China: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.4. Blood Glucose Monitoring Device Market - India
  - 7.5.4.1. India: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.5.4.2. India: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.5. Blood Glucose Monitoring Device Market - Malaysia
  - 7.5.5.1. Malaysia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.5.5.2. Malaysia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.6. Blood Glucose Monitoring Device Market - Japan
  - 7.5.6.1. Japan: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.5.6.2. Japan: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.7. Blood Glucose Monitoring Device Market - Indonesia
  - 7.5.7.1. Indonesia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.5.7.2. Indonesia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.8. Blood Glucose Monitoring Device Market - South Korea
  - 7.5.8.1. South Korea: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.5.8.2. South Korea: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.9. Blood Glucose Monitoring Device Market - Australia
  - 7.5.9.1. Australia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.5.9.2. Australia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.5.10. Blood Glucose Monitoring Device Market - Rest of Asia Pacific
  - 7.5.10.1. Rest of Asia Pacific: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.5.10.2. Rest of Asia Pacific: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
7.6. Blood Glucose Monitoring Device Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.6.2. Middle East & Africa: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.6.3. Blood Glucose Monitoring Device Market - Saudi Arabia
  - 7.6.3.1. Saudi Arabia: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.6.3.2. Saudi Arabia: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.6.4. Blood Glucose Monitoring Device Market - UAE
  - 7.6.4.1. UAE: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.6.4.2. UAE: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.6.5. Blood Glucose Monitoring Device Market - Israel
  - 7.6.5.1. Israel: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.6.5.2. Israel: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.6.6. Blood Glucose Monitoring Device Market - South Africa
  - 7.6.6.1. South Africa: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.6.6.2. South Africa: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.6.7. Blood Glucose Monitoring Device Market - Rest of Middle East & Africa
  - 7.6.7.1. Rest of Middle East & Africa: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.6.7.2. Rest of Middle East & Africa: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
7.7. Blood Glucose Monitoring Device Market - Latin America
- 7.7.1. Latin America: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
- 7.7.2. Latin America: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.7.3. Blood Glucose Monitoring Device Market - Mexico
  - 7.7.3.1. Mexico: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.7.3.2. Mexico: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.7.4. Blood Glucose Monitoring Device Market - Brazil
  - 7.7.4.1. Brazil: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.7.4.2. Brazil: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.7.5. Blood Glucose Monitoring Device Market - Argentina
  - 7.7.5.1. Argentina: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.7.5.2. Argentina: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)
- 7.7.6. Blood Glucose Monitoring Device Market - Rest of Latin America
  - 7.7.6.1. Rest of Latin America: Blood Glucose Monitoring Device Market, by Product, 2020-2034 (USD Billion)
  - 7.7.6.2. Rest of Latin America: Blood Glucose Monitoring Device Market, by End Use, 2020-2034 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Abbott Laboratories
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Acon Laboratories, Inc.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. ARKRAY Inc.
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Bayer AG
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. BD
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Dexcom, Inc.
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. F. Hoffmann-La Roche Ltd.
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. Johnson & Johnson
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Medtronic Plc
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. Novo Nordisk A/S
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Sanofi
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
9.12. Terumo Corporation
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
9.13. Ypsomed
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development